Safety and efficacy of Empagliflozin in Pakistani Muslim patients with type 2 diabetes (SAFE-PAK); a randomized clinical trial.
Aamir AH, Raja UY, Qureshi FM, Asghar A, Mahar SA, Ahmed I, Ghaffar T, Zafar J, Hasan MI, Riaz A, Raza SA, Khosa IA, Khan J, Baqar JB.
Aamir AH, et al. Among authors: raja uy.
BMC Endocr Disord. 2022 Nov 28;22(1):295. doi: 10.1186/s12902-022-01213-1.
BMC Endocr Disord. 2022.
PMID: 36443769
Free PMC article.
Clinical Trial.